Preparing for Post-Market Clinical Follow-Up Under EU MDR

The introduction of the EU MDR post-COVID has brought about transformative changes to PMCF, ushering in more stringent requirements. As manufacturers gear up to meet these new mandates, strategically aligning their PMCF data collection and compliance efforts is imperative. With the right resources, tools, and expert guidance, manufacturers can adeptly navigate these requirements, ensuring their devices remain compliant and market-ready in the post-COVID era.

This whitepaper will help you understand the primary challenges confronting the industry’s commercial model in the wake of the updated EU MDR guideline. By addressing these transformative factors, you can craft an operating model for your business that fits current demands.

Who should read this guide:

• Medical device manufacturers who track evolving industry regulations to stay compliant and build a successful regulatory strategy.
• Clinical data professionals who work on medical device studies and must understand how to collect European Union Medical Device Regulation (EU MDR)-compliant data.
• Regulatory affairs professionals who seek to improve their skills in the regulatory environment.

What you’ll learn:

• Recent updates to the EU MDR
• How EU MDR affects post-market surveillance and post-market clinical follow-up (PMCF)
• Challenges and benefits of PMCF for medical device companies
• How to create a PMCF plan to fit the requirements
• How to choose a PMCF solution

To understand the complexities of PMCF, download our whitepaper today.